Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
3369 | 1999 | 39.0 | 80% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
176 | 3 | DIABETES CARE//ENDOCRINOLOGY & METABOLISM//TYPE 2 DIABETES | 58057 |
1415 | 2 | DIPEPTIDYL PEPTIDASE IV//CD26//AMINOPEPTIDASE | 7997 |
3369 | 1 | DIPEPTIDYL PEPTIDASE IV//CD26//DIPEPTIDYL PEPTIDASE | 1999 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | DIPEPTIDYL PEPTIDASE IV | authKW | 2525185 | 15% | 54% | 307 |
2 | CD26 | authKW | 1974780 | 9% | 71% | 183 |
3 | DIPEPTIDYL PEPTIDASE | authKW | 828165 | 4% | 66% | 82 |
4 | DPP IV | authKW | 673394 | 5% | 46% | 96 |
5 | FIBROBLAST ACTIVATION PROTEIN | authKW | 558553 | 2% | 76% | 48 |
6 | SEPRASE | authKW | 397656 | 1% | 96% | 27 |
7 | DPP9 | authKW | 336018 | 1% | 100% | 22 |
8 | DPP8 | authKW | 320745 | 1% | 100% | 21 |
9 | FIBROBLAST ACTIVATION PROTEIN ALPHA | authKW | 318191 | 1% | 83% | 25 |
10 | DPP4 | authKW | 279138 | 2% | 48% | 38 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Chemistry, Medicinal | 4359 | 14% | 0% | 287 |
2 | Biochemistry & Molecular Biology | 1487 | 26% | 0% | 515 |
3 | Immunology | 1354 | 14% | 0% | 280 |
4 | Cell Biology | 888 | 13% | 0% | 251 |
5 | Medicine, Research & Experimental | 599 | 8% | 0% | 151 |
6 | Oncology | 495 | 10% | 0% | 203 |
7 | Chemistry, Organic | 478 | 9% | 0% | 171 |
8 | Endocrinology & Metabolism | 341 | 6% | 0% | 125 |
9 | Biophysics | 326 | 6% | 0% | 114 |
10 | Pharmacology & Pharmacy | 268 | 9% | 0% | 187 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | THER Y DEV INNOVAT IMMUNE DISORDERS CAN | 136063 | 1% | 64% | 14 |
2 | IMMUNOPHARM | 123714 | 0% | 90% | 9 |
3 | JOINT CANC CELL BIOL | 122180 | 1% | 67% | 12 |
4 | CLIN IMMUNOLMINATO KU | 56378 | 1% | 31% | 12 |
5 | AW MORROW GASTROENTEROL LIVER | 44267 | 1% | 11% | 26 |
6 | UNIV CLIN DERMATOL VENEREOL | 42290 | 0% | 46% | 6 |
7 | BIOTECHNOL PHARMACEUT | 33648 | 2% | 7% | 32 |
8 | FRANZ PENZOLDT | 33584 | 1% | 20% | 11 |
9 | BIOCHEM EXPT ONCOL | 32873 | 1% | 15% | 14 |
10 | CENTENARY CANC MED CELL BIOL DISCIPLINE | 30547 | 0% | 100% | 2 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 7075 | 5% | 0% | 109 |
2 | ADVANCES IN EXPERIMENTAL MEDICINE AND BIOLOGY | 4818 | 4% | 0% | 73 |
3 | BIOLOGISCHES ZENTRALBLATT | 1906 | 0% | 1% | 9 |
4 | BIOLOGICAL CHEMISTRY HOPPE-SEYLER | 1421 | 1% | 1% | 12 |
5 | BIOLOGICAL CHEMISTRY | 1194 | 1% | 1% | 16 |
6 | JOURNAL OF MEDICINAL CHEMISTRY | 1187 | 2% | 0% | 42 |
7 | FRONTIERS IN BIOSCIENCE-LANDMARK | 1066 | 1% | 0% | 16 |
8 | IMMUNOBIOLOGY | 1056 | 1% | 0% | 15 |
9 | ACTA HISTOCHEMICA | 919 | 1% | 0% | 13 |
10 | CHEMICAL BIOLOGY & DRUG DESIGN | 906 | 1% | 1% | 10 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | DIPEPTIDYL PEPTIDASE IV | 2525185 | 15% | 54% | 307 | Search DIPEPTIDYL+PEPTIDASE+IV | Search DIPEPTIDYL+PEPTIDASE+IV |
2 | CD26 | 1974780 | 9% | 71% | 183 | Search CD26 | Search CD26 |
3 | DIPEPTIDYL PEPTIDASE | 828165 | 4% | 66% | 82 | Search DIPEPTIDYL+PEPTIDASE | Search DIPEPTIDYL+PEPTIDASE |
4 | DPP IV | 673394 | 5% | 46% | 96 | Search DPP+IV | Search DPP+IV |
5 | FIBROBLAST ACTIVATION PROTEIN | 558553 | 2% | 76% | 48 | Search FIBROBLAST+ACTIVATION+PROTEIN | Search FIBROBLAST+ACTIVATION+PROTEIN |
6 | SEPRASE | 397656 | 1% | 96% | 27 | Search SEPRASE | Search SEPRASE |
7 | DPP9 | 336018 | 1% | 100% | 22 | Search DPP9 | Search DPP9 |
8 | DPP8 | 320745 | 1% | 100% | 21 | Search DPP8 | Search DPP8 |
9 | FIBROBLAST ACTIVATION PROTEIN ALPHA | 318191 | 1% | 83% | 25 | Search FIBROBLAST+ACTIVATION+PROTEIN+ALPHA | Search FIBROBLAST+ACTIVATION+PROTEIN+ALPHA |
10 | DPP4 | 279138 | 2% | 48% | 38 | Search DPP4 | Search DPP4 |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | KLEMANN, C , WAGNER, L , STEPHAN, M , VON HORSTEN, S , (2016) CUT TO THE CHASE: A REVIEW OF CD26/DIPEPTIDYL PEPTIDASE-4'S (DPP4) ENTANGLEMENT IN THE IMMUNE SYSTEM.CLINICAL AND EXPERIMENTAL IMMUNOLOGY. VOL. 185. ISSUE 1. P. 1 -21 | 134 | 71% | 6 |
2 | LAMBEIR, AM , DURINX, C , SCHARPE, S , DE MEESTER, I , (2003) DIPEPTIDYI-PEPTIDASE IV FROM BENCH TO BEDSIDE: AN UPDATE ON STRUCTURAL PROPERTIES, FUNCTIONS, AND CLINICAL ASPECTS OF THE ENZYME DPP IV.CRITICAL REVIEWS IN CLINICAL LABORATORY SCIENCES. VOL. 40. ISSUE 3. P. 209 -294 | 238 | 51% | 401 |
3 | WAUMANS, Y , BAERTS, L , KEHOE, K , LAMBEIR, AM , DE MEESTER, I , (2015) THE DIPEPTIDYL PEPTIDASE FAMILY, PROLYL OLIGOPEPTIDASE, AND PROLYL CARBOXYPEPTIDASE IN THE IMMUNE SYSTEM AND INFLAMMATORY DISEASE, INCLUDING ATHEROSCLEROSIS.FRONTIERS IN IMMUNOLOGY. VOL. 6. ISSUE . P. - | 157 | 61% | 12 |
4 | CORDERO, OJ , SALGADO, FJ , NOGUEIRA, M , (2009) ON THE ORIGIN OF SERUM CD26 AND ITS ALTERED CONCENTRATION IN CANCER PATIENTS.CANCER IMMUNOLOGY IMMUNOTHERAPY. VOL. 58. ISSUE 11. P. 1725 -1749 | 184 | 58% | 75 |
5 | AUGUSTYNS, K , VAN DER VEKEN, P , SENTEN, K , HAEMERS, A , (2005) THE THERAPEUTIC POTENTIAL OF INHIBITORS OF DIPEPTIDYL PEPTIDASE IV (DPP IV) AND RELATED PROLINE-SPECIFIC DIPEPTIDYL AMINOPEPTIDASES.CURRENT MEDICINAL CHEMISTRY. VOL. 12. ISSUE 8. P. 971 -998 | 179 | 72% | 53 |
6 | OHNUMA, K , HOSONO, O , DANG, NH , MORIMOTO, C , (2011) DIPEPTIDYL PEPTIDASE IN AUTOIMMUNE PATHOPHYSIOLOGY.ADVANCES IN CLINICAL CHEMISTRY, VOL 53. VOL. 53. ISSUE . P. 51 -84 | 144 | 75% | 24 |
7 | THOMPSON, MA , OHNUMA, K , ABE, M , MORIMOTO, C , DANG, NH , (2007) CD26/DIPEPTIDYL PEPTIDASE IV AS A NOVEL THERAPEUTIC TARGET FOR CANCER AND IMMUNE DISORDERS.MINI-REVIEWS IN MEDICINAL CHEMISTRY. VOL. 7. ISSUE 3. P. 253 -273 | 153 | 79% | 30 |
8 | WAGNER, L , KLEMANN, C , STEPHAN, M , VON HORSTEN, S , (2016) UNRAVELLING THE IMMUNOLOGICAL ROLES OF DIPEPTIDYL PEPTIDASE 4 (DPP4) ACTIVITY AND/OR STRUCTURE HOMOLOGUE (DASH) PROTEINS.CLINICAL AND EXPERIMENTAL IMMUNOLOGY. VOL. 184. ISSUE 3. P. 265 -283 | 106 | 76% | 4 |
9 | YU, DMT , YAO, TW , CHOWDHURY, S , NADVI, NA , OSBORNE, B , CHURCH, WB , MCCAUGHAN, GW , GORRELL, MD , (2010) THE DIPEPTIDYL PEPTIDASE IV FAMILY IN CANCER AND CELL BIOLOGY.FEBS JOURNAL. VOL. 277. ISSUE 5. P. 1126 -1144 | 130 | 77% | 61 |
10 | SMELCEROVIC, A , MILJKOVIC, F , KOLAREVIC, A , LAZAREVIC, J , DJORDJEVIC, A , KOCIC, G , ANDERLUH, M , (2015) AN OVERVIEW OF RECENT DIPEPTIDYL PEPTIDASE-IV INHIBITORS: LINKING THEIR STRUCTURE AND PHYSICO-CHEMICAL PROPERTIES WITH SAR, PHARMACOKINETICS AND TOXICITY.CURRENT TOPICS IN MEDICINAL CHEMISTRY. VOL. 15. ISSUE 23. P. 2342 -2372 | 118 | 88% | 1 |
Classes with closest relation at Level 1 |